# Rexulti

NDC: 70518-3548
Generic name: brexpiprazole
Labeler / Manufacturer: REMEDYREPACK INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20221003

FDA application: NDA205422

## Active ingredients

- BREXPIPRAZOLE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70518-3548"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70518-3548
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6991c065-0f6e-433a-8f4f-796e0ece327f